Please wait a minute...
J Zhejiang Univ (Med Sci)  2020, Vol. 49 Issue (2): 209-214    DOI: 10.3785/j.issn.1008-9292.2020.03.15
    
Roles of multidisciplinary team in diagnosis and treatment of suspected cases of COVID-19
DING Shubo1(),YU Shi'an2,CHEN Haijun3,*(),ZHANG Dehe3,XU Yejin3,ZHU Dan4,CHENG Kun5
1. Department of Oncology Radiotherapy, Jinhua Municipal Central Hospital, Jinhua 321000, Zhejiang Province, China
2. Department of Hepatobiliary Surgery, Jinhua Municipal Central Hospital, Jinhua 321000, Zhejiang Province, China
3. Department of Infectious Diseases, Jinhua Municipal Central Hospital, Jinhua 321000, Zhejiang Province, China
4. Department of Respiratory and Critical Care Medicine, Jinhua Municipal Central Hospital, Jinhua 321000, Zhejiang Province, China
5. Department of Critical Care Medicine, Jinhua Municipal Central Hospital, Jinhua 321000, Zhejiang Province, China
Download: HTML( 21 )   PDF(1052KB)
Export: BibTeX | EndNote (RIS)      

Abstract  

Objective: To analyze the roles of multidisciplinary team (MDT) in the diagnosis and treatment of suspected cases of coronavirus disease 2019 (COVID-19). Methods: The clinical data of 48 patients with suspected COVID-19 admitted in Jinhua Municipal Central Hospital from January 21, 2020 to March 20, 2020 were retrospectively analyzed. Results: In the 48 suspected cases, 18 were diagnosed with COVID-19, and 30 were excluded. Each of the confirmed cases were discussed among MDT for 2 to 12 times with an average of (4.7±3.2) times; while for non-COVID-19 patients were discussed for 2 to 4 times with an average of (2.3±0.6) times. With the guidance of MDT, one COVID-19 patient was transferred to designated provincial hospital after effective treatment; one patient complicated with acute cholecystitis underwent gallbladder puncture and drainage; and COVID-19 was excluded in a highly suspected patient after alveolar lavage fluid examination. Except one transferred patient, all 17 confirmed COVID-19 patients were cured and discharged. There was no cross-infection occurred in suspected patients during the hospitalization. There were no deaths and no medical staff infections. Conclusion: The efficiency of diagnosis and treatment for suspected COVID-19 patients can be improved with MDT, particularly for complicated cases.



Key wordsCoronavirus disease 2019      Severe acute respiratory syndrome coronavirus 2      Novel coronavirus pneumonia      Suspected case      Multidisciplinary team      Diagnosis      Treatment     
Received: 04 March 2020      Published: 10 April 2020
CLC:  R511  
Corresponding Authors: CHEN Haijun     E-mail: jhyyys@163.com;jhchenhaijun@126.com
Cite this article:

DING Shubo,YU Shi'an,CHEN Haijun,ZHANG Dehe,XU Yejin,ZHU Dan,CHENG Kun. Roles of multidisciplinary team in diagnosis and treatment of suspected cases of COVID-19. J Zhejiang Univ (Med Sci), 2020, 49(2): 209-214.

URL:

http://www.zjujournals.com/med/10.3785/j.issn.1008-9292.2020.03.15     OR     http://www.zjujournals.com/med/Y2020/V49/I2/209


2019冠状病毒病(COVID-19)疑似患者多学科协作诊治分析

目的: 分析多学科协作诊疗(MDT)在2019冠状病毒病(COVID-19)疑似病例诊治中的参与情况及处置结果,总结MDT在COVID-19诊治中的作用。方法: 回顾性分析2020年1月21日至3月20日就诊于金华市中心医院的48例COVID-19疑似患者的临床资料及诊治经过,进一步分析MDT在患者处置流程和诊断中的作用。结果: 18例确诊COVID-19,30例排除COVID-19。确诊患者经MDT讨论2~12次,平均每例患者讨论(4.7±3.2)次;非COVID-19患者多学科讨论2~4次,平均每例患者讨论(2.3±0.6)次。MDT对COVID-19疑似患者诊疗流程及诊断标准进行了讨论及调整。在MDT主导下,1例危重型患者积极治疗后转省级定点医院治疗,1例COVID-19合并急性胆囊炎患者行胆囊穿刺置管引流术手术,1例高度疑似患者行肺泡灌洗液检查排除COVID-19。除1例COVID-19危重型患者转省级医院治疗外,17例COVID-19患者均治愈出院,未发现院内及疑似患者交叉感染,无死亡病例,无医务人员感染发生,非COVID-19患者及时转到相应专科治疗。结论: 在COVID-19疑似患者诊治过程中,MDT的参与提高了诊治效率,尤其对疑难复杂病例诊治有重要作用。


关键词: 2019冠状病毒病,  严重急性呼吸综合征冠状病毒2,  新型冠状病毒肺炎,  疑似病例,  多学科协作,  诊断,  治疗 
[1]   PAULES C I , MARSTON H D , FAUCI A S . Coronavirus infections-more than just the common cold[J]. JAMA, 2020, 323 (8): 707- 708
doi: 10.1001/jama.2020.0757
[2]   MUNSTER V J , KOOPMANS M , VAN DOREMALEN N A et al. A novel coronavirus emerging in China-key questions for impact assessment[J]. N Engl J Med, 2020, 382 (8): 692- 694
doi: 10.1056/NEJMp2000929
[3]   GUAN W J , NI Z Y , HU Y et al. Clinical characteristics of coronavirus disease 2019 in China[J]. N Engl J Med, 2020,
doi: 10.1056/NEJMoa2002032
[4]   YANG X , YU Y , XU J et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China:a single-centered, retrospective, observational study[J]. Lancet Respir Med, 2020,
doi: 10.1016/S2213-2600(20)30079-5
[5]   徐凯进, 蔡洪流, 沈毅弘 et al. 2019冠状病毒病(COVID-19)诊疗浙江经验[J]. 浙江大学学报(医学版), 2020, 49 (2): 147- 157
XU Kaijin , CAI Hongliu , SHEN Yihong et al. Management of COVID-19:the Zhejiang experience[J]. Journal of Zhejiang University (Medical Sciences), 2020, 49 (2): 147- 157
doi: 10.3785/j.issn.1008-9292.2020.02.02
[6]   中华人民共和国国家卫生健康委员会办公厅, 国家中医药管理局办公室.新型冠状病毒感染的肺炎诊疗方案(试行第六版)[A/OL].国卫办医函[2020] 145号.(2020-02-18)[2020-02-20].http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2.shtml.
General Office of National Health Commission of the People's Republic of China, Office of National Administration of Traditional Chinese Medicine. Diagnosis and treatment of novel coronavirus pneumonia (trial version 6)[A/OL]. No.145[2020] of the General Office of the National Health Commission. (2020-02-18)[2020-02-20]. http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2.shtml. (in Chinese)
[7]   HOLSHUE M L , DEBOLT C , LINDQUIST S et al. First case of 2019 novel coronavirus in the United States[J]. N Engl J Med, 2020, 382 (10): 929- 936
doi: 10.1056/NEJMoa2001191
[8]   周晶, 张德和, 陈海君 et al. 新型冠状病毒肺炎胸部CT表现不典型一例及文献复习[J]. 中华临床感染病杂志, 2020, 13 (1): 36- 38
ZHOU Jing , ZHANG Dehe , CHEN Haijun et al. Atypical chest CT in coronavirus disease:A case report and literature review[J]. Chinese Journal of Clinical Infectious Diseases, 2020, 13 (1): 36- 38
doi: 10.3760/cma.j.issn.1674-2397.2020.0002
[9]   周海华, 章义利, 周一波 et al. 新型冠状病毒肺炎合并急性胆囊炎手术治疗一例[J]. 中华外科杂志, 2020, 58
ZHOU Haihua , ZHANG Yili , ZHOU Yibo et al. A case of surgical treatment of new coronavirus pneumonia with acute cholecystitis[J]. Chinese Journal of Surgery, 2020, 58
doi: 10.3760/cma.j.cn112139-20200221-00114
[10]   上海市新型冠状病毒病临床救治专家组 . 上海市2019冠状病毒病综合救治专家共识[J]. 中华传染病杂志, 2020, 38
Shanghai Clinical Treatment Expert Group for Corona Virus Disease 2019 . Comprehensive treatment and management of coronavirus disease 2019:expert consensus statement from Shanghai[J]. Chinese Journal of Infectious Diseases, 2020, 38
doi: 10.3760/cma.j.issn.1000-6680.2020.0016
[1] CAO Shengli,FENG Peihua,SHI Pengpeng. Study on the epidemic development of COVID-19 in Hubei province by a modified SEIR model[J]. J Zhejiang Univ (Med Sci), 2020, 49(2): 178-184.
[2] CHEN Jun,LIU Danping,LIU Li,LIU Ping,XU Qingnian,XIA Lu,LING Yun,HUANG Dan,SONG Shuli,ZHANG Dandan,QIAN Zhiping,LI Tao,SHEN Yinzhong,LU Hongzhou. A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19[J]. J Zhejiang Univ (Med Sci), 2020, 49(2): 215-219.
[3] WANG Jincheng,LIU Jinpeng,WANG Yuanyuan,LIU Wei,CHEN Xiaoqun,SUN Chao,SHEN Xiaoyong,WANG Qidong,WU Yaping,LIANG Wenjie,RUAN Lingxiang. Dynamic changes of chest CT imaging in patients with COVID-19[J]. J Zhejiang Univ (Med Sci), 2020, 49(2): 191-197.
[4] ZHANG Xiaoyan, SUN Wei, SHANG Shiqiang, MAO Jianhua, FU Junfen, SHU Qiang, JIANG Kewen. Principles and suggestions on biosafety protection of biological specimen preservation during prevalence of COVID-19[J]. J Zhejiang Univ (Med Sci), 2020, 49(2): 170-177.
[5] CHEN Zhimin,FU Junfen,SHU Qiang,WANG Wei,CHEN Yinghu,HUA Chunzhen,LI Fubang,LIN Ru,TANG Lanfang,WANG Tianlin,WANG Yingshuo,XU Weize,YANG Zihao,YE Sheng,YUAN Tianming,ZHANG Chenmei,ZHANG Yuanyuan. Diagnosis and treatment recommendation for pediatric COVID-19 (the second edition)[J]. J Zhejiang Univ (Med Sci), 2020, 49(2): 139-146.
[6] XU Kaijin,CAI Hongliu,SHEN Yihong,NI Qin,CHEN Yu,HU Shaohua,LI Jianping,WANG Huafen,YU Liang,HUANG He,QIU Yunqing,WEI Guoqing,FANG Qiang,ZHOU Jianying,SHENG Jifang,LIANG Tingbo,LI Lanjuan. Management of COVID-19: the Zhejiang experience[J]. J Zhejiang Univ (Med Sci), 2020, 49(2): 147-157.
[7] JIANG Saiping,LI Lu,RU Renping,ZHANG Chunhong,RAO Yuefeng,LIN Bin,WANG Rongrong,CHEN Na,WANG Xiaojuan,CAI Hongliu,SHENG Jifang,ZHOU Jianying,LU Xiaoyang,QIU Yunqing. Pharmaceutical care for severe and critically ill patients with COVID-19[J]. J Zhejiang Univ (Med Sci), 2020, 49(2): 158-169.
[8] LI Xin,DAI Tian,WANG Hong,SHI Junnian,YUAN Wei,LI Jing,CHEN Lijun,ZHANG Tianming,ZHANG Shanshan,KONG Yan,YUE Ning,SHI Hui,HE Yuping,HU Huifang,LIU Furong,YANG Caixia. Clinical analysis of suspected COVID-19 patients with anxiety and depression[J]. J Zhejiang Univ (Med Sci), 2020, 49(2): 203-208.
[9] LUO Song,YANG Lijuan,WANG Chun,LIU Chuanmiao,LI Dianming. Clinical observation of 6 severe COVID-19 patients treated with plasma exchange or tocilizumab[J]. J Zhejiang Univ (Med Sci), 2020, 49(2): 227-231.
[10] HONG Dongsheng,NI Jian,SHAN Wenya,LI Lu,HU Xi,YANG Hongyu,ZHAO Qingwei,ZHANG Xingguo. Establishment of a rapid identification of adverse drug reaction program in R language implementation based on monitoring data[J]. J Zhejiang Univ (Med Sci), 2020, 49(2): 253-259.
[11] ZHONG Qi,LI Zhi,SHEN Xiaoyong,XU Kaijin,SHEN Yihong,FANG Qiang,CHEN Feng,LIANG Tingbo. CT imaging features of patients with different clinical types of COVID-19[J]. J Zhejiang Univ (Med Sci), 2020, 49(2): 198-202.
[12] KANG Xianhui,ZHANG Rong,HE Huiliang,YAO Yongxing,ZHENG Yueying,WEN Xiaohong,ZHU Shengmei. Anesthesia management in cesarean section for patient with COVID-19: a case report[J]. J Zhejiang Univ (Med Sci), 2020, 49(2): 249-252.
[13] CHEN Xu,LI Yang,WANG Jinxi,CAI Hongliu,CAO Hongcui,SHENG Jifang. Pregnant women complicated with COVID-19: a clinical analysis of 3 cases[J]. J Zhejiang Univ (Med Sci), 2020, 49(2): 240-244.
[14] SHEN Lihua,HUANG Fei,CHEN Xiang,XIONG Zuan,YANG Xiaoyu,LI Hui,CHENG Feng,GUO Jian,GONG Guofu. Diagnostic efficacy of three test kits for SARS-CoV-2 nucleic acid detection[J]. J Zhejiang Univ (Med Sci), 2020, 49(2): 185-190.
[15] ZHAGN Sheng,LI Danping,CHEN Huazhong,ZHENG Dan,ZHOU Yiping,CHEN Baoguo,SHI Weiwu,LIN Ronghai. Dynamic inflammatory response in a critically ill COVID-19 patient treated with corticosteroids[J]. J Zhejiang Univ (Med Sci), 2020, 49(2): 220-226.